Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06214598

Anti-Inflammatory Diet in BRC Patients on Aromatase Inhibitors

Anti-Inflammatory Dietary Intervention in Breast Cancer Patients Receiving Aromatase Inhibitors

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
University of Belgrade · Academic / Other
Sex
Female
Age
45 Years – 70 Years
Healthy volunteers
Not accepted

Summary

This project aims to decrease undesirable side effects and increase qulaity of life of aromatase inhibitors therapy in breast cancer survivors, by anti-inflammatory diet or supplementation.

Detailed description

With 2.1 million new breast cancer (BRC) cases each year globally, BRC is one of the biggest health challenges today. Available anticancer therapies have limited efficacy and are coupled with toxic side effects. Nutritional intervention can ameliorate undesirable effects, reduce exhaustion, psychological harm, and costs spent on treating these side effects. The proposed project AID aims to improve clinical outcome, quality of life (QoL) and survival rate in BRC patients on adjuvant endocrine therapy with aromatase inhibitors (AI) by nutritional interventions. In a three-arm randomised controlled nutritional trial involving 90 BRC patients who will receive either supplement or placebo pills (control group), or an anti-inflammatory diet for 4 months, along with the AI therapy, changes in nutritional status, QoL, biochemical and clinical parameters will be measured in comparison among three groups. The second goal is to establish cause-and-effect relationships among the clinical outcomes, nutritional status and biochemical parameters related to cancer, including inflammatory and redox status, plasma lipidome and polymorphism of fatty acid desaturase (FADS) genes. Introducing an effective nutritional intervention in BRC patients as an integral part of the multimodal therapeutic approach is the goal of this project.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTSupplementSupplements of anti-inflammatory oils rich in omega-3 and gamma-linolenic acid
DIETARY_SUPPLEMENTAI dietdiet rich in whole grains, healthy oils and polyphenols,
DIETARY_SUPPLEMENTPlaceboPlacebo caps with standard diet

Timeline

Start date
2024-03-01
Primary completion
2025-03-31
Completion
2026-11-30
First posted
2024-01-19
Last updated
2024-05-09

Locations

2 sites across 1 country: Serbia

Source: ClinicalTrials.gov record NCT06214598. Inclusion in this directory is not an endorsement.